A phase 3, randomized, double-blind study of luspatercept (ACE-536) in patients (pts) with Revised International Prognostic Scoring System (IPSS-R) very low- to intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions: The MEDALIST trial

Uwe Platzbecker; Rami S. Komrokji; Pierre Fenaux; Guillermo Garcia-Manero; Ghulam J. Mufti; Mikkael A. Sekeres; Jennie Zhang; Aziz Benzohra; Abderrahmane Laadem; Bond Vo; Kenneth M. Attie; Alan F. List

doi:10.1200/JCO.2016.34.15_suppl.TPS7076

Back

A phase 3, randomized, double-blind study of luspatercept (ACE-536) in patients (pts) with Revised International Prognostic Scoring System (IPSS-R) very low- to intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions: The MEDALIST trial

Journal article

Peer reviewed

A phase 3, randomized, double-blind study of luspatercept (ACE-536) in patients (pts) with Revised International Prognostic Scoring System (IPSS-R) very low- to intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions: The MEDALIST trial

Uwe Platzbecker, Rami S. Komrokji, Pierre Fenaux, Guillermo Garcia-Manero, Ghulam J. Mufti, Mikkael A. Sekeres, Jennie Zhang, Aziz Benzohra, Abderrahmane Laadem, Bond Vo, …

Journal of clinical oncology, Vol.34(15_suppl), pp.TPS7076-TPS7076

2016-05-20

DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.TPS7076

Metrics

6 Record Views

Details

Title: A phase 3, randomized, double-blind study of luspatercept (ACE-536) in patients (pts) with Revised International Prognostic Scoring System (IPSS-R) very low- to intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (RS) who require red blood cell (RBC) transfusions: The MEDALIST trial
Creators: Uwe Platzbecker - TU Dresden
Rami S. Komrokji - Moffitt Cancer Center
Pierre Fenaux - Hôpital Saint-Louis
Guillermo Garcia-Manero - The University of Texas MD Anderson Cancer Center
Ghulam J. Mufti - King's College Hospital
Mikkael A. Sekeres - Cleveland Clinic
Jennie Zhang - Bristol-Myers Squibb
Aziz Benzohra - Bristol-Myers Squibb
Abderrahmane Laadem - Bristol-Myers Squibb
Bond Vo - Bristol-Myers Squibb
Kenneth M. Attie - Acceleron Pharma
Alan F. List - Moffitt Cancer Center
Publication Details: Journal of clinical oncology, Vol.34(15_suppl), pp.TPS7076-TPS7076
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031758093602976